TY - JOUR T1 - Automated Detection Model in Classification B-Lymphoblast Cell from Normal B-Lymphoid Precursors in Blood Smear Microscopic Images Based on the Majority Voting Technique JF - medRxiv DO - 10.1101/2021.07.10.21260312 SP - 2021.07.10.21260312 AU - Mustafa Ghaderzadeh AU - Azamossadat Hosseini AU - Farkhondeh Asadi AU - Hassan Abolghasemi AU - Arash Roshanpour Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/15/2021.07.10.21260312.abstract N2 - Introduction Acute Lymphoblastic Leukemia (ALL) is a deadly white blood cell disease that affects the human bone marrow. Detection of ALL, the most common type of leukemia, has been always riddled with complexity and difficulty in its early stages. Peripheral blood examination as a common method at the beginning of the ALL diagnosis process is a time-consuming, tedious process and greatly depends on the experts’ experience, keeping up with the advances in artificial intelligence in the diagnosis process. Keeping up with the growth and development of artificial intelligence algorithms a model was developed to classify B-ALL lymphoblast cells from lymphocytes.Materials and Methods A Fast, efficient and comprehensive model based on Deep Learning (DL) was proposed by implementing eight well-known Convolutional Neural Network (CNN) models for feature extraction on all images and evaluating in classifying B-ALL lymphoblast and Normal. After evaluating their performance, four best-performing CNN models were selected to compose an ensemble classifier, by combining the model performance of each classifier.Results Due to the close similarity of the nuclei of cancerous and normal blood B-ALL cells, the state-of-the-art CNN models alone did not achieve acceptable performance in diagnosing these two classes and their sensitivity was low. The proposed classification model Based on the majority voting technique was adopted to combine the CNN models. The sensitivity of 99.4, the specificity of 96.7, AUC of 98.3, and accuracy of 98.5 were obtained for the proposed model.Conclusion To classify blood cancerous cells from normal cells, the proposed method can achieve high accuracy without the intervention of the operator in cell feature determination. Thus, the DL-based model can be recommended as an extraordinary tool for the analysis of blood samples in digital laboratory equipment to assist laboratory specialists.Competing Interest Statementthere is no competing interest. Funding StatementThis study was part of a PhD project conducted at Shahid Beheshti University of Medical Sciences, Tehran, Iran, was approved by Iran National Committee for Ethics in Biomedical Research with Approval ID IR.SBMU.RETECH.REC.1399.735Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Shahid Beheshti University of Medical SciencesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is public and accessible https://biomedicalimaging.org/2019/challenges/ ER -